M&R Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $310K | Buy |
4,937
+14
| +0.3% | +$817 | 0.07% | 107 |
|
|
2024
Q2 | $291K | Sell |
4,923
-143,553
| -97% | -$8.98M | 0.07% | 107 |
|
|
2024
Q1 | $11.8M | Sell |
148,476
-2,383
| -2% | -$182K | 2.9% | 10 |
|
|
2023
Q4 | $11.9M | Sell |
150,859
-7,210
| -5% | -$513K | 2.98% | 9 |
|
|
2023
Q3 | $11M | Sell |
158,069
-3,545
| -2% | -$251K | 3.02% | 8 |
|
|
2023
Q2 | $11.2M | Sell |
161,614
-4,825
| -3% | -$343K | 2.92% | 8 |
|
|
2023
Q1 | $12.4M | Sell |
166,439
-2,387
| -1% | -$200K | 3.47% | 8 |
|
|
2022
Q4 | $15.7M | Sell |
168,826
-1,170
| -0.7% | -$113K | 4.33% | 4 |
|
|
2022
Q3 | $16.2M | Buy |
169,996
+455
| +0.3% | +$45K | 4.58% | 3 |
|
|
2022
Q2 | $15.7M | Sell |
169,541
-622
| -0.4% | -$60.7K | 4.11% | 3 |
|
|
2022
Q1 | $17.3M | Buy |
170,163
+1,064
| +0.6% | +$112K | 3.69% | 5 |
|
|
2021
Q4 | $17.4M | Sell |
169,099
-263
| -0.2% | -$24.3K | 3.61% | 6 |
|
|
2021
Q3 | $14.4M | Buy |
169,362
+59
| +0% | +$4.94K | 3.26% | 6 |
|
|
2021
Q2 | $14.1M | Buy |
169,303
+664
| +0.4% | +$54.4K | 3.24% | 9 |
|
|
2021
Q1 | $12.7M | Buy |
168,639
+261
| +0.2% | +$19K | 3.16% | 8 |
|
|
2020
Q4 | $11.5M | Buy |
168,378
+4,790
| +3% | +$312K | 2.62% | 12 |
|
|
2020
Q3 | $9.54M | Buy |
163,588
+4,931
| +3% | +$307K | 2.37% | 15 |
|
|
2020
Q2 | $10.3M | Sell |
158,657
-1,627
| -1% | -$102K | 2.76% | 9 |
|
|
2020
Q1 | $9.51M | Buy |
160,284
+4,306
| +3% | +$287K | 2.83% | 6 |
|
|
2019
Q4 | $11.6M | Sell |
155,978
-3,949
| -2% | -$277K | 2.6% | 7 |
|
|
2019
Q3 | $10.1M | Buy |
159,927
+30,733
| +24% | +$1.82M | 2.34% | 8 |
|
|
2019
Q2 | $7.04M | Sell |
129,194
-932
| -0.7% | -$50.2K | 1.59% | 20 |
|
|
2019
Q1 | $6.96M | Buy |
130,126
+3,794
| +3% | +$234K | 1.59% | 20 |
|
|
2018
Q4 | $8.28M | Sell |
126,332
-174
| -0.1% | -$13K | 2.16% | 10 |
|
|
2018
Q3 | $9.96M | Buy |
126,506
+62,452
| +97% | +$4.46M | 2.18% | 10 |
|
|
2018
Q2 | $4.13M | Buy |
64,054
+462
| +0.7% | +$30.4K | 0.95% | 34 |
|
|
2018
Q1 | $3.96M | Buy |
63,592
+2,238
| +4% | +$161K | 0.92% | 34 |
|
|
2017
Q4 | $4.45M | Sell |
61,354
-7,684
| -11% | -$559K | 1.03% | 28 |
|
|
2017
Q3 | $5.61M | Sell |
69,038
-1,905
| -3% | -$151K | 1.35% | 26 |
|
|
2017
Q2 | $5.63M | Sell |
70,943
-4,300
| -6% | -$340K | 1.4% | 24 |
|
|
2017
Q1 | $5.91M | Sell |
75,243
-440
| -0.6% | -$35.1K | 1.48% | 22 |
|
|
2016
Q4 | $5.97M | Sell |
75,683
-6,186
| -8% | -$501K | 1.61% | 20 |
|
|
2016
Q3 | $7.29M | Sell |
81,869
-2,240
| -3% | -$211K | 2.06% | 14 |
|
|
2016
Q2 | $8.05M | Buy |
84,109
+55,383
| +193% | +$5.52M | 2.36% | 9 |
|
|
2016
Q1 | $2.98M | Buy |
28,726
+1,630
| +6% | +$158K | 0.9% | 35 |
|
|
2015
Q4 | $2.65M | Buy |
27,096
+350
| +1% | +$34.3K | 0.76% | 40 |
|
|
2015
Q3 | $2.58M | Buy |
26,746
+625
| +2% | +$65.7K | 0.71% | 44 |
|
|
2015
Q2 | $2.74M | Sell |
26,121
-425
| -2% | -$43.4K | 0.65% | 45 |
|
|
2015
Q1 | $2.74M | Sell |
26,546
-165
| -0.6% | -$16.7K | 0.65% | 44 |
|
|
2014
Q4 | $2.57M | Sell |
26,711
-275
| -1% | -$24.2K | 0.61% | 45 |
|
|
2014
Q3 | $2.15M | Sell |
26,986
-200
| -0.7% | -$15.8K | 0.51% | 52 |
|
|
2014
Q2 | $2.05M | Sell |
27,186
-450
| -2% | -$34K | 0.48% | 49 |
|
|
2014
Q1 | $2.07M | Sell |
27,636
-75
| -0.3% | -$5.3K | 0.5% | 46 |
|
|
2013
Q4 | $1.98K | Sell |
27,711
-400
| -1% | -$25.7K | 0.52% | 44 |
|
|
2013
Q3 | $1.59M | Buy |
28,111
+100
| +0.4% | +$5.96K | 0.45% | 47 |
|
|
2013
Q2 | $1.6M | Buy |
+28,011
| New | +$1.62M | 0.46% | 48 |
|
Other funds holding CVS
M&R Capital Management's CVS Position: Q3 2024 in Review
M&R Capital Management increased its CVS Health (CVS) stake by 0.28% in Q3 2024, buying an estimated $817 and bringing the position to 4,937 shares worth $310K. The position accounts for 0.07% of the portfolio, ranked #107.
M&R Capital Management first reported a position in CVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $17.4M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- M&R Capital Management held 4,937 shares of CVS Health worth $310K as of Q3 2024.
- M&R Capital Management bought 14 CVS Health shares in Q3 2024, an estimated $817.
- CVS Health made up 0.07% of M&R Capital Management's portfolio in Q3 2024, its #107 holding.
- M&R Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 46 quarters since.
- M&R Capital Management's CVS Health position peaked at $17.4M in Q4 2021.
- 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.